Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation

Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation

BackgroundGalectin‐3 may play a role in cardiac and noncardiac fibrosis, and elevated circulating levels of this protein predict adverse outcomes in patients with heart failure who do not have congenital heart disease. We investigated galectin‐3 in adults with single‐ventricle Fontan circulation, pa...

Full description

Bibliographic Details
Main Authors: Alexander R. Opotowsky, Fernando Baraona, Justin Owumi, Brittani Loukas, Michael N. Singh, Anne Marie Valente, Fred Wu, Susan Cheng, Gruschen Veldtman, Eric B. Rimm, Michael J. Landzberg
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
adult congenital heart disease
biomarker
congenital heart disease
Fontan procedure
galectin‐3
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.115.002706

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.115.002706

Similar Items